Insider Trading June 5, 2026 05:43 PM

Lemonade's Chief Insurance Officer Offloads Shares Amid Volatile Trading Period

Executive divestment coincides with near-term price declines, though recent earnings performance exceeded analyst projections.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
LMND

John Sheldon Peters, Lemonade's Chief Insurance Officer, executed two separate sales of company stock this week totaling $283,257. The transactions occurred against a backdrop of an 11% weekly decline in Lemonade's share price, bringing the current valuation to $51.46. While the sales were driven by tax obligations and a pre-arranged trading plan, the timing aligns with a period of heightened stock volatility. Despite the recent price weakness, the insurer recently reported first-quarter 2026 financial results that surpassed Wall Street expectations, prompting mixed analyst responses regarding its fair value and operational momentum.

Lemonade's Chief Insurance Officer Offloads Shares Amid Volatile Trading Period
LMND
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Lemonade's Chief Insurance Officer sold $283,257 in shares through non-discretionary tax withholding and a Rule 10b5-1 plan, with prices between $52.94 and $53.17.
  • The insurer reported first-quarter 2026 earnings that beat Wall Street expectations, with EPS of -$0.47 vs -$0.57, revenue of $258M vs $251.5M, and adjusted gross profit of $101M vs $88M.
  • Analyst sentiment is mixed: Citizens lowered its price target to $80 but kept a Market Outperform rating, while Cantor Fitzgerald maintained an Overweight rating with a $92 target, citing operational momentum.

John Sheldon Peters, serving as the Chief Insurance Officer for Lemonade, Inc. (NASDAQ: LMND), has executed a series of stock sales totaling $283,257 in value. The divestment was completed through two distinct transactions during the current week, with execution prices ranging between $52.94 and $53.17 per share. This activity emerges as Lemonade's equity has experienced a contraction of approximately 11% over the preceding seven-day period, placing the stock at a current trading level of $51.46.

According to data from InvestingPro, the company's shares are currently positioned near their calculated Fair Value. However, the platform highlights that LMND generally exhibits high price volatility, suggesting that short-term fluctuations may not necessarily reflect long-term fundamental shifts. Investors seeking deeper financial metrics and additional ProTips can access comprehensive data through the InvestingPro platform.

On June 3, 2026, Mr. Peters disposed of 1,735 shares at an average price of $53.17. This specific transaction was classified as non-discretionary, intended solely to satisfy tax withholding obligations associated with the vesting and settlement of his Restricted Stock Units. The following day, June 4, 2026, Peters sold an additional 3,608 shares of Lemonade common stock at $52.94 per share. This second transaction was carried out under the parameters of a Rule 10b5-1 trading plan, a mechanism designed to allow executives to trade company stock during restricted periods while complying with securities regulations.

These executive transactions occur against a backdrop of recent corporate developments for Lemonade. The insurer recently reported its first-quarter 2026 earnings, delivering results that exceeded Wall Street consensus estimates. The company posted an earnings per share (EPS) of -$0.47, outperforming the anticipated loss of -$0.57. Revenue also surpassed expectations, reaching $258 million against a forecast of $251.5 million. Furthermore, Lemonade reported an adjusted gross profit of $101 million, which beat both Citizens' estimate of $82 million and broader consensus expectations of $88 million.

Despite the positive earnings report, analysts have shown mixed sentiment regarding the stock's valuation. Citizens adjusted its price target for Lemonade downward from $85 to $80, while maintaining a Market Outperform rating. Conversely, Cantor Fitzgerald reiterated an Overweight rating with a higher price target of $92, citing confidence in the company's operating momentum despite the recent weak stock performance.

In terms of operational expansion, Lemonade has launched its renters insurance product in Louisiana and Delaware. The company states that this coverage starts at $5 per month and is approximately 30% less expensive than the national average. These developments underscore Lemonade's ongoing efforts to expand its market presence and improve financial performance metrics. The company's stock closed at $51.46, reflecting a decrease of $0.15 or 0.29%. After-hours trading saw the price dip further to $51.00, down $0.46 or 0.89%.

Investors assessing whether LMND represents a bargain can utilize the Fair Value calculator, which employs 17 proven industry valuation models to determine accuracy. This tool is part of a broader suite of AI-picked strategies designed to help investors identify undervalued stocks with potential upside.

Risks

  • The stock has declined approximately 11% over the past week and currently trades near its Fair Value, indicating potential short-term volatility and valuation uncertainty for investors.
  • While earnings beat expectations, the company reported a net loss per share of -$0.47, highlighting ongoing profitability challenges despite revenue growth.
  • The launch of new renters insurance products in Louisiana and Delaware represents a market expansion effort, but the success of this lower-priced product line relative to national averages may impact margin profiles and competitive positioning.

More from Insider Trading

Dillard’s Director J.C. Watts Jr. Executes $243,671 Stock Sale Jun 5, 2026 Ichor Holdings CEO Executes Pre-Arranged Share Sale Under Rule 10b5-1 Plan Jun 5, 2026 908 Devices Director Christopher Brown Executes Pre-Arranged Stock Sale Jun 5, 2026 Krystal Biotech R&D Chief Krishnan Offloads $7.7M in Shares Under Pre-Arranged Plan Jun 5, 2026 Krystal Biotech Executive Krishnan Sells $7.7M in Pre-Arranged Plan Amid Strong Financials Jun 5, 2026